Skip to content

Using Video Images to Improve Advance Care Planning in Patients With Cancer

Using Video Images to Improve Advance Care Planning in Patients With Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00970125
Enrollment
80
Registered
2009-09-02
Start date
2009-08-31
Completion date
2011-06-30
Last updated
2012-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer

Keywords

advance care planning, cancer

Brief summary

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone.

Detailed description

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone. Subjects will choose among three goals of care, life prolonging care, basic medical care, and comfort care.

Interventions

BEHAVIORALvideo

outline of the goals of care

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition: * All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR * Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR * Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma. * The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional). 2. Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic). 3. English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools. 4. Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient. 5. Able to provide informed consent. 6. Age greater than or equal to 21.

Exclusion criteria

1. MMSE \< 25. 2. Psychological state not appropriate for end-of-life discussion as determined by the treating clinician.

Design outcomes

Primary

MeasureTime frame
end of life preference at time of interview5 minutes after survey

Secondary

MeasureTime frame
knowledge5 minutes after survey
decisional conflict5 minutes after survey

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026